IMMUNE-MEDIATED PANCYTOPENIA

This adverse event was reported 49 times

IMMUNE-MEDIATED PANCYTOPENIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TOCILIZUMAB-AAZG 1 0.0016
1 LISOCABTAGENE MARALEUCEL 1 0.0011
2 APREPITANT 6 0.0008
3 EPIRUBICIN HYDROCHLORIDE 3 0.0005
4 FOSAPREPITANT DIMEGLUMINE 6 0.0004
5 PEMBROLIZUMAB 37 0.0003
6 PEGFILGRASTIM 2 0.0002
7 TIGECYCLINE 1 0.0002
8 PEMETREXED DISODIUM 6 0.0002
9 CARBOPLATIN 17 0.0001
See all drugs enriched for association with IMMUNE-MEDIATED PANCYTOPENIA